A!Maginostic is an A*STAR-IMCB spin-off and biotech startup focused on delivering Digital Pathology solutions for medical/clinical research. It has Research Collaborative Agreements with multiple clinical institutions such as SGH and NUH among others.
A!maginostic focuses on pushing the quantitative and reliable cellular/ molecular image analysis and diagnosis solutions from academic research to clinical decision making, i.e., diagnosis and prognosis.
The core technical team has more than ten years of experience in designing and fast prototyping robust solutions for cellular image analysis and molecule diagnosis.
We integrate methodologies from multiple fields, such as signal processing, image processing and computer vision, optimization, machine learning, pattern recognition, mathematical modeling, Artificial Intelligence (AI), Deep Learning (DL) with the input from Pathologists, Oncologists, and Cell Biologists.
Our goal is to provide efficient, accurate and robust digital pathology algorithms/solutions for patients/clinicians and improve healthcare for the public.
Company Details
- Employees
- 3
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.aimaginostic.com
A!maginostic Questions
A!Maginostic's website is https://www.aimaginostic.com
A!Maginostic's LinkedIn profile is https://www.linkedin.com/company/aimaginostic
A!Maginostic has
3 employees.
View email and phone details for 3
employees at A!Maginostic.
A!Maginostic's industry is
Biotechnology Research
A!Maginostic's top competitors are
Virasoft Corporation,
Pathology Ai Lab,
Digital Pathology Lab,
Paige - Ai Website Builder,
Evyd Technology,
Histoindex,
Zayaai,
Digital Pathology And Ai,
Albatroz Therapeutics,
Medmain Inc..
A!Maginostic's categories are Biotechnology Research
A!Maginostic's founding year is 2017
